Emerging agents for onychomycosis

B. M. Piraccini, M. Iorizzo, G. Rech, Antonella Tosti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60% to 80%, and relapses are not rare (up to 20% of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presented.

Original languageEnglish
Pages (from-to)155-159
Number of pages5
JournalGiornale Italiano di Dermatologia e Venereologia
Volume141
Issue number2
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Onychomycosis
Nail Diseases
Recurrence
Therapeutics
Pharmaceutical Preparations

Keywords

  • Antimicotics
  • Nails
  • Posaconazole
  • Ravuconazole
  • Voriconazole

ASJC Scopus subject areas

  • Dermatology

Cite this

Piraccini, B. M., Iorizzo, M., Rech, G., & Tosti, A. (2006). Emerging agents for onychomycosis. Giornale Italiano di Dermatologia e Venereologia, 141(2), 155-159.

Emerging agents for onychomycosis. / Piraccini, B. M.; Iorizzo, M.; Rech, G.; Tosti, Antonella.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 141, No. 2, 01.01.2006, p. 155-159.

Research output: Contribution to journalArticle

Piraccini, BM, Iorizzo, M, Rech, G & Tosti, A 2006, 'Emerging agents for onychomycosis', Giornale Italiano di Dermatologia e Venereologia, vol. 141, no. 2, pp. 155-159.
Piraccini BM, Iorizzo M, Rech G, Tosti A. Emerging agents for onychomycosis. Giornale Italiano di Dermatologia e Venereologia. 2006 Jan 1;141(2):155-159.
Piraccini, B. M. ; Iorizzo, M. ; Rech, G. ; Tosti, Antonella. / Emerging agents for onychomycosis. In: Giornale Italiano di Dermatologia e Venereologia. 2006 ; Vol. 141, No. 2. pp. 155-159.
@article{644a858e5fc249ceb7d31446cafff40d,
title = "Emerging agents for onychomycosis",
abstract = "Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60{\%} to 80{\%}, and relapses are not rare (up to 20{\%} of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presented.",
keywords = "Antimicotics, Nails, Posaconazole, Ravuconazole, Voriconazole",
author = "Piraccini, {B. M.} and M. Iorizzo and G. Rech and Antonella Tosti",
year = "2006",
month = "1",
day = "1",
language = "English",
volume = "141",
pages = "155--159",
journal = "Giornale Italiano di Dermatologia e Venereologia",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Emerging agents for onychomycosis

AU - Piraccini, B. M.

AU - Iorizzo, M.

AU - Rech, G.

AU - Tosti, Antonella

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60% to 80%, and relapses are not rare (up to 20% of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presented.

AB - Onychomycosis is the most common nail disease and describes the invasion of the nail by fungi. In most cases, treatment of onychomycosis requires systemic antifungals, with duration of administration ranging from 2 to several months. Cure rates range from 60% to 80%, and relapses are not rare (up to 20% of patients). New antifungals providing higher cure rates and less relapses are, therefore, auspicable. A review of onychomycoses and their treatment is made and the new antifungal drugs that are currently on study or already available are presented.

KW - Antimicotics

KW - Nails

KW - Posaconazole

KW - Ravuconazole

KW - Voriconazole

UR - http://www.scopus.com/inward/record.url?scp=33646834300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646834300&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33646834300

VL - 141

SP - 155

EP - 159

JO - Giornale Italiano di Dermatologia e Venereologia

JF - Giornale Italiano di Dermatologia e Venereologia

SN - 0392-0488

IS - 2

ER -